Just because a business does not make any money, does not mean that the stock will go down. For example, biotech ...

Q4 2024 Earnings Call Transcript March 27, 2025 INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.4, ...

S&P 500 components Deere and Allstate are in focus for this week's stock market. Sea Ltd., Ollie's Bargain and Travere Therapeutics are also stocks to watch. The major indexes fell sharply Friday ...

Raymond James Financial Inc. purchased a new position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free ...

StockNews.com initiated coverage on shares of bluebird bio (NASDAQ:BLUE – Free Report) in a report published on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. A ...

Research and Development (“R&D”) Expenses : R&D expenses for the three months ended December 31, 2024, were $8.2 million, compared to $13.5 million for the same period in 2023. The decrease was due ...

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands ...

On January 28, 2025, the Company received clearance of its IND from the FDA to initiate a first-in-human Phase 1 dose ...

A Durham company is pushing back on media reports questioning the safety of its lead product as the firm begins its commercial launch.

Learn more about whether Alvotech or Vericel Corporation is a better investment based on AAII's A+ Investor grades, which ...

Learn more about whether Alvotech or Protagonist Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades ...